The present invention is 3-({3-(4-chlorophenyl)-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hydroxypropyl]-4,5-dihydro -1H-1,2,4-triazol-1-yl}methyl)-1-[3-(trifluoromethyl)-pyridin-2-yl]-1H-1,2,4-triazole-5 -Carboxamide, 3-({3-(4-chlorophenyl)-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hydroxypropyl]-4,5- Dihydro-1H-1,2,4-triazol-1-yl}methyl)-1-[2-(trifluoromethyl)phenyl]-1H-1,2,4-triazole-5-carbox Amide and 3-({3-(4-chlorophenyl)-5-oxo-4-[(2S)-3,3,3-trifluoro-2-hydroxypropyl]-4,5-dihydro- Prodrug of 1H-1,2,4-triazol-1-yl}methyl)-1-(3-chloropyridin-2-yl)-1H-1,2,4-triazole-5-carboxamide , Methods of making such compounds, pharmaceutical compositions containing such compounds, and the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of kidney and cardiovascular diseases.본 발명은 3-({3-(4-클로로페닐)-5-옥소-4-[(2S)-3,3,3-트리플루오로-2-히드록시프로필]-4,5-디히드로-1H-1,2,4-트리아졸-1-일}메틸)-1-[3-(트리플루오로메틸)-피리딘-2-일]-1H-1,2,4-트리아졸-5-카르복스아미드, 3-({3-(4-클로로페닐)-5-옥소-4-[(2S)-3,3,3-트리플루오로-2-히드록시프로필]-4,5-디히드로-1H-1,2,4-트리아졸-1-일}메틸)-1-[2-(트리플루오로메틸)페닐]-1H-1,2,4-트리아졸-5-카르복스아미드 및 3-({3-(4-클로로페닐)-5-옥소-4-[(2S)-3,3,3-트리플루오로-2-히드록시프로필]-4,5-디히드로-1H-1,2,4-트리아졸-1-일}메틸)-1-(3-클로로피리딘-2-일)-1H-1,2,4-트리아졸-5-카르복스아미드의 전구약물, 이러한 화합물의 제조 방법, 이러한 화합물을 함유하는 제약 조성물, 및 질환의 치료 및/또는 예방, 특히 신장 질환 및 심혈관 질환의 치료 및/또는 예방을 위한 이러한 화합물 또는 조성물의 용도에 관한 것이다.